{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:58:12Z","timestamp":1781197092756,"version":"3.54.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtocrr.2026.100993","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:28:49Z","timestamp":1774546129000},"page":"100993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Patient With Novel PPP1CB-ALK Fusion Advanced NSCLC Achieved Long Survival From Alectinib: A Case Report"],"prefix":"10.1016","volume":"7","author":[{"given":"Chang\u2019e","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3912-0930","authenticated-orcid":false,"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2026.100993_bib1","article-title":"Catalog of 5' fusion partners in ALK-positive NSCLC Circa 2020","volume":"1","author":"Ou","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jtocrr.2026.100993_bib2","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.21037\/tlcr-24-667","article-title":"A rationale for the poor response to alectinib in a patient with adenocarcinoma of the lung harbouring a STRN-ALK fusion by artificial intelligence and molecular modelling: a case report","volume":"13","author":"Barberis","year":"2024","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtocrr.2026.100993_bib3","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2023.7107","article-title":"Response of a novel KANK1::ALK fusion to alectinib in an advanced lung adenocarcinoma: a case report","volume":"22","author":"Tang","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtocrr.2026.100993_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-228248","article-title":"Unusual high-grade and low-grade glioma in an infant with PPP1CB-ALK gene fusion","volume":"12","author":"Ng","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jtocrr.2026.100993_bib5","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41467-019-12187-5","article-title":"Alterations in ALK\/ROS1\/NTRK\/MET drive a group of infantile hemispheric gliomas","volume":"10","author":"Guerreiro Stucklin","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtocrr.2026.100993_bib6","article-title":"Novel MRPL13-ALK and PPP1CB-ALK double-fusion as a potential mechanism of acquired resistance to first-line osimertinib in EGFR-mutant high grade neuroendocrine tumor of the lung","volume":"1","author":"Jiao","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jtocrr.2026.100993_bib7","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.3390\/curroncol29100530","article-title":"STRN-ALK fusion in lung adenocarcinoma with brain metastasis responded well to ensartinib: a case report","volume":"29","author":"Zhang","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jtocrr.2026.100993_bib8","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.3390\/curroncol29100618","article-title":"Therapeutic advances of rare ALK fusions in non-small cell lung cancer","volume":"29","author":"Xiang","year":"2022","journal-title":"Curr Oncol"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364326000445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364326000445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:58:42Z","timestamp":1781193522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364326000445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666364326000445"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2026.100993","relation":{},"ISSN":["2666-3643"],"issn-type":[{"value":"2666-3643","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Patient With Novel PPP1CB-ALK Fusion Advanced NSCLC Achieved Long Survival From Alectinib: A Case Report","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2026.100993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100993"}}